This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
HDFP Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reducation in mortality in persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562–2571.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255–3264.
Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S . Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. BMJ 1997; 315: 154–159.
Hasford J, Mimran A, Simons WR . A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens 2002; 16: 569–575.
Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP . Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995; 311: 293–295.
Burke TA, Sturkenboom MC, Lu S, Wentworth CE, Liu Y, Rhoads GG . Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24: 1193–1200.
Mazzaglia G, Mantovani LG, Sturkenboom MCJM, Filippi A, Trifiro G, Cricelli C et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23: 2093–2100.
The ALLHAT Officers Co-ordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000; 283: 1967–1975.
The Antihypertensive Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. Journal of the American Medical Association—Express 2002; 288: 2981–2997.
Brown MJ . Hypertension and ethnic group. BMJ 2006; 332: 833–836.
Wright JM, Lee CH, Chambers GK . Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ 1999; 161: 25–32.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Wong, M. Short- and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: cohort study. J Hum Hypertens 22, 435–437 (2008). https://doi.org/10.1038/jhh.2008.13
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2008.13
This article is cited by
-
Persistence to antihypertensive drug treatment in Swedish primary healthcare
European Journal of Clinical Pharmacology (2013)
-
Profiles of discontinuation and switching of thiazide diuretics: a cohort study among 9398 Chinese hypertensive patients
Hypertension Research (2011)
-
Switching of antihypertensive drugs among 93 286 Chinese patients: a cohort study
Journal of Human Hypertension (2010)
-
Factors Associated With Antihypertensive Drug Discontinuation Among Chinese Patients: A Cohort Study
American Journal of Hypertension (2009)
-
Factors Associated With Compliance, Discontinuation and Switching of Calcium Channel Blockers in 20,156 Chinese Patients
American Journal of Hypertension (2009)